NanoLogix Bacteria Detection Plates Break Longevity Records Using Anthrax as Reference Bacteria
NanoLogix Demolishes Competition In Room Temperature Storage Tests
HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix Inc. (OTC: NNLX), the biotechnology company focused primarily on rapid diagnostics, is pleased to announce independent tests show extraordinary success in testing of a revolutionary new packaging technology for the long-term, room-temperature storage of Petri plates used for bacteria detection. Tested with Anthrax as reference bacteria, and designed for use in detection of a multitude of bacteria, this achievement may be the biggest single improvement to century-old Petri-dish-based technology in decades.
NanoLogix nitrogen-charged FlatPack Petri plates stored at room temperature for six months provided growth and detection of Anthrax equivalent to competitor's new Petri plates, according to results of third-party testing conducted by a large independent laboratory. The nationally known competitor’s product delivered degraded results after just two months, the lab said, citing results after testing had reached a six-month comparison point. All tests were conducted using Tryptic Soy Agar (TSA), a world standard nutrient agar for bacterial detection. The tests also demonstrated an astonishingly reduced time to results of 14 hours for detection of Anthrax with NanoLogix FlatPack TSA, compared to historic norms of 24 hours using the competitor TSA.
FlatPack room-temperature preservation technology leapfrogs current standards, under which TSA petri plates remain usable for only three months in cold storage – that is, 2 to 8 degrees Centigrade, or 36 to 46 degrees Fahrenheit, according to NanoLogix. FlatPack technology eliminates the need for refrigeration of TSA and extends the usable life of the TSA agar by multiples of what is available from competitors. In addition, FlatPack technology provides for easy visibility of all ten plates per pack for quality inspection, and reduces or eliminates breakage during shipping and storage. After shipping tens of thousands of plates, NanoLogix has been told by customers that not a single plate has broken.
The testing showed reduced results for the competitor’s Petri plates after the first two months of testing at room temperatures. At that point, NanoLogix Petri plates provided results essentially identical to new plates. After four months at room temperature, the nutrient agar in the competitor’s Petri plates had completely dried out and was unusable for detection, while NanoLogix’s Petri plates again provided identical results to new plates, the third-party lab said.
After five and six months at room temperature, due to the desiccated nature of the agar in the competitor’s Petri plates, the lab changed comparison for control purposes to compare NanoLogix’s Petri plates to the competitor’s fresh, just-delivered nutrient plates. At both data points, NanoLogix’s Flatpack-preserved Petri plates provided the equivalent in detection results to fresh Petri plates.
The current testing process, a follow-up to the successful one-year cold storage tests for NanoLogix TSA that were completed in 2012, will continue for an additional six months.
NanoLogix to Exhibit at the American Society for Microbiology (ASM) BioDefense and Emerging
Diseases Research Meeting in Washington DC, 25-27 February 2013.
The Company will exhibit its technology at booth 38 in the MARRIOTT WARDMAN PARK - HALLS B SOUTH & C, 2660 Woodley Rd. NW, Washington, DC 20008
"After shipping tens of thousands of plates, NanoLogix has been told by customers that not a single plate has broken."
That single sentence contains a lot of very good news for shareholders.
Also, interesting that they used Anthrax as the test subject when they will be presenting at the ASM in a week.
Sentiment: Strong Buy
What makes you think the margins are sufficient? In a low-margin, high volume product channel, a small operation can easily be beaten by a larger one via economies of scale in production and distribution.
I'm pro-nanotechnology with this company, and I'm not sure the packaging is a good investment in Management's time and efforts, at the expense of the high-margin, hi-tech rapid testing products. They may have a patent on their particular process, but I don't see how shrink-wrap + nitrogen is so novel that others can't do it another way without violating NNLX patent.
Let's see movement with the core product! If you want to tout packaging, show me some convincing numbers.
Here we go again... "according to results of third-party testing conducted by a large independent laboratory. " Same o, same o. The news is great but it isn't going to have any significant impact on the pps. At this point in the company's development, only increasing sales numbers and revs are going to increase the pps now. I like #1's comment about the company perhaps finding other ways to exploit the packaging technology. That could be as much a winner as the plate technology applications.
The product works and is great.
We all agree this testing was done by Battelle correct?
Big announcement coming that all of their and their client's plates will be bought from Nanologix?
Someone posted a joint PR with Battelle and a client doing business together on this board not long ago.
Battelle does go public now concerning joint ventures with their clients.
Why not a joint PR with Nanologix?
I would think that would get a lot of attention and would also be a great sale's tool.
how much revenue do you think they can generate from this new petri packaging.. and will tehy get respectable margins? Are tehre any competing methods or applications. has anyone even reserched this stuff at all, or just turned a blind eye to the hopeful dream that this is the best in market, without even assessing the viability. Is this just a ploy to show some revenue on the books?